Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.82M Sell
68,652
-375
-0.5% -$43.9K 0.11% 112
2026
Q1
$8.3M Sell
69,027
-2,027
-3% -$234K 0.14% 103
2025
Q4
$7.48M Buy
71,054
+1,846
+3% +$173K 0.13% 121
2025
Q3
$5.81M Buy
69,208
+7,513
+12% +$619K 0.11% 135
2025
Q2
$4.88M Sell
61,695
-461
-0.7% -$36.6K 0.1% 144
2025
Q1
$5.58M Hold
62,156
– – 0.13% 130
2024
Q4
$6.18M Buy
+62,156
New +$6.41M 0.13% 126

Other funds holding MRK

GF Fund Management's MRK Position: Q2 2026 in Review

GF Fund Management reduced its Merck (MRK) stake by 0.54% in Q2 2026, selling an estimated $43.9K and leaving 68,652 shares worth $8.82M. The position accounts for 0.11% of the portfolio, ranked #112.

GF Fund Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GF Fund Management held 68,652 shares of Merck worth $8.82M as of Q2 2026.
  • GF Fund Management sold 375 Merck shares in Q2 2026, an estimated $43.9K.
  • Merck made up 0.11% of GF Fund Management's portfolio in Q2 2026, its #112 holding.
  • GF Fund Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.